Genome-wide analysis shows no genomic predictors of ovarian response to stimulation by exogenous FSH for IVF

Reproductive BioMedicine Online

Volumn 22, Issue 4, 2011, Pages 382-388

  Van Disseldorp, Jeroen ^a   Franke, Lude ^b   Eijkemans, Rene ^a   Broekmans, Frank ^a   MacKlon, Nick ^a,c   Wijmenga, Cisca ^b   Fauser, Bart ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

genes; genome wide association study; IVF; ovarian response; ovarian stimulation

Indexed keywords

CETRORELIX; CHORIONIC GONADOTROPIN; GANIRELIX; MUELLERIAN INHIBITING FACTOR; RECOMBINANT FOLLITROPIN;

ADULT; APOPTOSIS; ARTICLE; BODY MASS; CAUCASIAN; CELL CYCLE REGULATION; CLINICAL ASSESSMENT; CRYOPRESERVATION; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; FOLLICULAR ASPIRATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOMICS; GRANULOSA CELL; HORMONAL THERAPY; HUMAN; LUTEAL PHASE; OOCYTE RETRIEVAL; OVARIAN RESPONSE; OVARIAN STIMULATION; OVARY FUNCTION; PHARMACOGENOMICS; PREGNANCY TEST; PROGNOSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; LIKELIHOOD FUNCTIONS; OOCYTES; OVARY; POLYMORPHISM, SINGLE NUCLEOTIDE; PREGNANCY;

EID: 79953740058     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rbmo.2010.12.006     Document Type: Article

References (43)

1. Aittomaki, K., Lucena, J.L., Pakarinen, P., et al., 1995. Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell 82, 959-968.
2. Altmae, S., Haller, K., Peters, M., et al., 2009. Aromatase gene (CYP19A1) variants, female infertility and ovarian stimulation outcome: a preliminary report. Reprod. Biomed. Online 18, 651-657.
3. Behre, H.M., Greb, R.R., Mempel, A., et al., 2005. Significance of a common single nucleotide polymorphism in exon 10 of the follicle-stimulating hormone (FSH) receptor gene for the ovarian response to FSH: a pharmacogenetic approach to controlled ovarian hyperstimulation. Pharmacogenet. Genomics 15, 451-456. (Pubitemid 41017593)
4. Bellver, J., Ayllon, Y., Ferrando, M., et al., 2010. Female obesity impairs in vitro fertilization outcome without affecting embryo quality. Fertil. Steril. 93, 447-454.
5. Ben-Shlomo, I., Vitt, U.A., Hsueh, A.J., 2002. Perspective: the ovarian kaleidoscope database-II. Functional genomic analysis of an organ-specific database. Endocrinology 143, 2041-2044.
6. Bertrand, J., Treluyer, J.M., Panhard, X., et al., 2009. Influence of pharmacogenetics on indinavir disposition and short-term response in HIV patients initiating HAART. Eur. J. Clin. Pharmacol. 65, 667-678.
7. Broekmans, F.J., Soules, M.R., Fauser, B.C., 2009. Ovarian aging: mechanisms and clinical consequences. Endocr. Rev. 30, 465-493.
8. Byun, E., Caillier, S.J., Montalban, X., et al., 2008. Genome-wide pharmacogenomic analysis of the response to interferon beta therapy in multiple sclerosis. Arch. Neurol. 65, 337-344.
9. de Castro, F., Ruiz, R., Montoro, L., et al., 2003. Role of follicle-stimulating hormone receptor Ser680Asn polymorphism in the efficacy of follicle-stimulating hormone. Fertil. Steril. 80, 571-576.
10. de Castro, F., Moron, F.J., Montoro, L., et al., 2004. Human controlled ovarian hyperstimulation outcome is a polygenic trait. Pharmacogenetics 14, 285-293. (Pubitemid 38638915)
11. Dumesic, D.A., Lesnick, T.G., Stassart, J.P., Ball, G.D., Wong, A., Abbott, D.H., 2008. Intrafollicular antimullerian hormone levels predict follicle responsiveness to follicle-stimulating hormone (FSH) in normoandrogenic ovulatory women undergoing gonadotropin releasing-hormone analog/recombinant human FSH therapy for in vitro fertilization and embryo transfer. Fertil. Steril. 92, 217-221.
12. Elbers, C.C., van Eijk, K.R., Franke, L., et al., 2009. Using genome-wide pathway analysis to unravel the etiology of complex diseases. Genet. Epidemiol. 33, 419-431.
13. ESHRE Capri Workshop Group, 2008. Genetic aspects of female reproduction. Hum. Reprod. Update 14, 293-307.
14. Falconer, H., Andersson, E., Aanesen, A., Fried, G., 2005. Follicle-stimulating hormone receptor polymorphisms in a population of infertile women. Acta Obstet. Gynecol. Scand. 84, 806-811.
15. Fauser, B.C., Diedrich, K., Devroey, P., 2008. Predictors of ovarian response: progress towards individualized treatment in ovulation induction and ovarian stimulation. Hum. Reprod. Update 14, 1-14.
16. Gerasimova, T., Thanasoula, M.N., Zattas, D., Seli, E., Sakkas, D., Lalioti, M.D., 2010. Identification and in vitro characterization of follicle stimulating hormone (FSH) receptor variants associated with abnormal ovarian response to FSH. J. Clin. Endocrinol. Metab. 95, 529-536.
17. Greb, R.R., Behre, H.M., Simoni, M., 2005a. Pharmacogenetics in ovarian stimulation-current concepts and future options. Reprod. Biomed. Online 11, 589-600.
18. Greb, R.R., Grieshaber, K., Gromoll, J., et al., 2005b. A common single nucleotide polymorphism in exon 10 of the human follicle stimulating hormone receptor is a major determinant of length and hormonal dynamics of the menstrual cycle. J. Clin. Endocrinol. Metab. 90, 4866-4872.
19. Jun, J.K., Yoon, J.S., Ku, S.Y., et al., 2006. Follicle-stimulating hormone receptor gene polymorphism and ovarian responses to controlled ovarian hyperstimulation for IVF-ET. J. Hum. Genet. 51, 665-670.
20. Kevenaar, M.E., Themmen, A.P., Laven, J.S., et al., 2007. Anti-Mullerian hormone and anti-Mullerian hormone type II receptor polymorphisms are associated with follicular phase estradiol levels in normo-ovulatory women. Hum. Reprod. 22, 1547-1554.
21. Knauff, E.A., Franke, L., van Es, M.A., et al., 2009. Genome-wide association study in premature ovarian failure patients suggests ADAMTS19 as a possible candidate gene. Hum. Reprod. 24, 2372-2378.
22. Laven, J.S., Mulders, A.G., Suryandari, D.A., et al., 2003. Follicle- stimulating hormone receptor polymorphisms in women with normogonadotropic anovulatory infertility. Fertil. Steril. 80, 986-992.
23. Legro, R.S., 2008. Individualizing infertility therapy with pharmacogenomics: vanity or vanguard? Pharmacogenomics 9, 1179-1181.
24. Loutradis, D., Patsoula, E., Minas, V., et al., 2006. FSH receptor gene polymorphisms have a role for different ovarian response to stimulation in patients entering IVF/ICSI-ET programs. J. Assist. Reprod. Genet. 23, 177-184.
25. Loutradis, D., Vlismas, A., Drakakis, P., Antsaklis, A., 2008. Pharmacogenetics in ovarian stimulation-current concepts. Ann. NY Acad. Sci. 1127, 10-19.
26. Lussiana, C., Guani, B., Mari, C., Restagno, G., Massobrio, M., Revelli, A., 2008. Mutations and polymorphisms of the FSH receptor (FSHR) gene: clinical implications in female fecundity and molecular biology of FSHR protein and gene. Obstet. Gynecol. Surv. 63, 785-795.
27. Olivennes, F., Howles, C.M., Borini, A., et al., 2009. Individualizing FSH dose for assisted reproduction using a novel algorithm: the CONSORT study. Reprod. Biomed. Online 18, 195-204.
28. Overbeek, A., Kuijper, E.A., Hendriks, M.L., et al., 2009. Clomiphene citrate resistance in relation to follicle-stimulating hormone receptor Ser680Ser-polymorphism in polycystic ovary syndrome. Hum. Reprod. 24, 2007-2013.
29. Perez Mayorga, M., Gromoll, J., Behre, H.M., Gassner, C., Nieschlag, E., Simoni, M., 2000. Ovarian response to follicle-stimulating hormone (FSH) stimulation depends on the FSH receptor genotype. J. Clin. Endocrinol. Metab. 85, 3365-3369.
30. Popovic-Todorovic, B., Loft, A., Lindhard, A., Bangsboll, S., Andersson, A.M., Andersen, A.N., 2003. A prospective study of predictive factors of ovarian response in 'standard' IVF/ICSI patients treated with recombinant FSH. A suggestion for a recombinant FSH dosage normogram. Hum. Reprod. 18, 781-787.
31. Purcell, S., Neale, B., Todd-Brown, K., et al., 2007. PLINK: a toolset for whole-genome association and population-based linkage analysis. Am. J. Hum. Genet. 81, 559-575.
32. Simoni, M., Gromoll, J., Hoppner, W., et al., 1999. Mutational analysis of the follicle-stimulating hormone (FSH) receptor in normal and infertile men: identification and characterization of two discrete FSH receptor isoforms. J. Clin. Endocrinol. Metab. 84, 751-755.
33. Simoni, M., Tempfer, C.B., Destenaves, B., Fauser, B.C., 2008. Functional genetic polymorphisms and female reproductive disorders: part I: polycystic ovary syndrome and ovarian response. Hum. Reprod. Update 14, 459-484.
34. Sterrenburg, M.D., Verhulst, S.M., Eijkemans, M.J., et al., 2009. The optimum daily dose of recombinant FSH for ovarian stimulation in IVF/ICSI; a meta-analysis. Hum. Reprod. 24, i43-i44.
35. Sudo, S., Kudo, M., Wada, S., Sato, O., Hsueh, A.J., Fujimoto, S., 2002. Genetic and functional analyses of polymorphisms in the human FSH receptor gene. Mol. Hum. Reprod. 8, 893-899.
36. Valkenburg, O., van Santbrink, E.J.P., Themmen, A.P.N., Uitterlinden, A.G., Fauser, B.C.J.M., Laven, J.S.E., 2009. FSH receptor polymorphism affects the outcome of ovulation induction in normogonadotropic anovulatory infertility (WHOII). Reprod. Sci. 16, 278A.
37. van der Gaast, M.H., Eijkemans, M.J., van der Net, J.B., et al., 2006. Optimum number of oocytes for a successful first IVF treatment cycle. Reprod. Biomed. Online 13, 476-480.
38. van der Zwaag, B., Franke, L., Poot, M., et al., 2009. Gene-network analysis identifies susceptibility genes related to glycobiology in autism. PLoS One 4, e5324.
39. Verberg, M.F., Eijkemans, M.J., Macklon, N.S., Heijnen, E.M., Fauser, B.C., Broekmans, F.J., 2007. Predictors of low response to mild ovarian stimulation initiated on cycle day 5 for IVF. Hum. Reprod. 22, 1919-1924.
40. Verberg, M.F., Eijkemans, M.J., Macklon, N.S., Heijnen, E.M., Fauser, B.C., Broekmans, F.J., 2008. Predictors of ongoing pregnancy after single-embryo transfer following mild ovarian stimulation for IVF. Fertil. Steril. 89, 1159-1165.
41. Verberg, M.F., Eijkemans, M.J., Macklon, N.S., et al., 2009. The clinical significance of the retrieval of a low number of oocytes following mild ovarian stimulation for IVF: a meta-analysis. Hum. Reprod. Update 15, 5-12.
42. Verhagen, T.E., Hendriks, D.J., Bancsi, L.F., Mol, B.W., Broekmans, F.J., 2008. The accuracy of multivariate models predicting ovarian reserve and pregnancy after in vitro fertilization: a meta-analysis. Hum. Reprod. Update 14, 95-100.
43. Wellcome Trust Case Control Consortium, 2007. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447, 661-678.